JP2016507520A5 - - Google Patents

Download PDF

Info

Publication number
JP2016507520A5
JP2016507520A5 JP2015555242A JP2015555242A JP2016507520A5 JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5 JP 2015555242 A JP2015555242 A JP 2015555242A JP 2015555242 A JP2015555242 A JP 2015555242A JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
hbc
seq
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016507520A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012586 external-priority patent/WO2014116730A2/en
Publication of JP2016507520A publication Critical patent/JP2016507520A/ja
Publication of JP2016507520A5 publication Critical patent/JP2016507520A5/ja
Pending legal-status Critical Current

Links

JP2015555242A 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド Pending JP2016507520A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361755850P 2013-01-23 2013-01-23
US61/755,850 2013-01-23
US201361901243P 2013-11-07 2013-11-07
US61/901,243 2013-11-07
PCT/US2014/012586 WO2014116730A2 (en) 2013-01-23 2014-01-22 Stabilized hepatitis b core polypeptide

Publications (2)

Publication Number Publication Date
JP2016507520A JP2016507520A (ja) 2016-03-10
JP2016507520A5 true JP2016507520A5 (enExample) 2017-03-30

Family

ID=51228185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555242A Pending JP2016507520A (ja) 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド

Country Status (5)

Country Link
US (1) US9896483B2 (enExample)
EP (1) EP2948469A4 (enExample)
JP (1) JP2016507520A (enExample)
CA (1) CA2936092A1 (enExample)
WO (1) WO2014116730A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
US10526376B2 (en) 2015-01-15 2020-01-07 University Of Copenhagen Virus-like particle with efficient epitope display
EP3368068B1 (en) 2015-10-30 2020-11-18 University of Copenhagen Virus like particle with efficient epitope display
CN106636016B (zh) * 2017-02-24 2020-03-17 天津大学 一种通过正负电荷引入辅助病毒样颗粒自组装的方法和应用
EP3723796A1 (en) * 2017-12-13 2020-10-21 CureVac AG Flavivirus vaccine
US11261216B2 (en) * 2018-12-28 2022-03-01 The Board Of Trustees Of The Leland Stanford Junior University Engineered hepatitis B core polypeptide
CN109666067A (zh) * 2019-01-07 2019-04-23 中国科学院过程工程研究所 一种重组病毒样颗粒及其制备方法和用途
EP3908591A4 (en) * 2019-01-11 2023-01-25 Agency for Science, Technology and Research USE OF HLA-A*11:01 RESTRICTED HEPATITIS B VIRUS (HBV) PEPTIDES TO IDENTIFY HBV-SPECIFIC CD8+ T CELLS

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008601A1 (en) 1992-10-14 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
WO1996002555A1 (en) 1994-07-15 1996-02-01 The University Of Iowa Research Foundation Immunomodulatory oligonucleotides
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5968767A (en) 1996-06-07 1999-10-19 Genentech, Inc. Methods for in vitro protein synthesis
US6593103B1 (en) 1997-02-07 2003-07-15 The Regents Of The University Of California HIV capsid assembly-associated compositions and method
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
WO1998055495A2 (en) 1997-06-06 1998-12-10 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
ATE249240T1 (de) * 1998-02-12 2003-09-15 Immune Complex Corp Strategisch modifizierte hepatitis b kernproteine und ihre derivate
ATE314095T1 (de) 1998-10-21 2006-01-15 Us Health Virusähnliche partikel zur induktion von autoantikörpern
KR100715954B1 (ko) * 1998-12-04 2007-05-09 바이오겐 아이덱 엠에이 인코포레이티드 펩티드 리간드에 의하여 부착된 다중 면역원성 성분을보유한 hbv 코어 항원 입자
US6994986B2 (en) 1999-03-17 2006-02-07 The Board Of Trustees Of The Leland Stanford University In vitro synthesis of polypeptides by optimizing amino acid metabolism
US6168931B1 (en) 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
US6337191B1 (en) 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US6548276B2 (en) 2000-09-06 2003-04-15 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
IL158418A0 (en) 2001-04-19 2004-05-12 Scripps Research Inst In vivo incorporation of unnatural amino acids
EP1450856B1 (en) 2001-09-14 2009-11-11 Cytos Biotechnology AG Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
AU2002366710A1 (en) 2001-12-20 2003-07-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
WO2003101972A1 (en) 2002-05-30 2003-12-11 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
WO2004016778A1 (en) 2002-08-19 2004-02-26 The Board Of Trustees Of The Leland Stanford Junior University Improved methods of in vitro protein synthesis
WO2004022585A1 (ja) * 2002-09-06 2004-03-18 Advanced Life Science Institute, Inc. 粒子形成能を有するhbvプレコア蛋白質
US20060240024A1 (en) 2003-02-28 2006-10-26 The Johns Hopkins University T cell regulation
RU2351362C2 (ru) 2003-03-26 2009-04-10 Цитос Байотекнолоджи Аг КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
BRPI0411475A (pt) 2003-06-18 2006-07-25 Scripps Research Inst adições de código genético de aminoácido reativo não natural
WO2005005614A2 (en) * 2003-07-03 2005-01-20 Pecos Labs, Inc. Combined b-cell and t-cell epitopes on vlp for improved vaccines
US20050054044A1 (en) 2003-07-18 2005-03-10 The Board Of Trustees Of The Leland Stanford Junior University Method of alleviating nucleotide limitations for in vitro protein synthesis
US7341852B2 (en) 2003-07-18 2008-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of decoupling reaction scale and protein synthesis yield in batch mode
WO2005034733A2 (en) 2003-10-08 2005-04-21 North Shore-Long Island Jewish Research Institute Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
JP5074768B2 (ja) 2003-11-20 2012-11-14 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ インビトロにおけるタンパク質合成の改良された方法
US20050170551A1 (en) 2004-02-04 2005-08-04 Strip David R. Manufacture of flat panel light emitting devices
EP1773303A2 (en) * 2004-05-25 2007-04-18 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
US7718410B2 (en) 2004-09-21 2010-05-18 The Scripps Research Institute In vivo incorporation of alkynyl amino acids into proteins in eubacteria
WO2006065751A2 (en) 2004-12-13 2006-06-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
ATE460922T1 (de) * 2006-04-07 2010-04-15 Chimeros Inc Zusammensetzungen und verfahren zur behandlung von b-zellen-malignomen
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US20110129438A1 (en) 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
WO2008002673A2 (en) 2006-06-29 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of virus like particles
AU2007325952B8 (en) 2006-06-29 2013-06-27 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
PT2064333E (pt) 2006-09-08 2014-06-09 Ambrx Inc Supressor híbrido arnt para células de vertebrados
AU2008205479A1 (en) 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US8445706B2 (en) 2008-09-05 2013-05-21 Board Of Trustees Of Northern Illinois University Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
WO2010042755A2 (en) * 2008-10-08 2010-04-15 Chimeros Inc. Chimeric therapeutics, compositions, and methods for using same
US20100168402A1 (en) 2008-11-14 2010-07-01 Bundy Bradley C Direct Attachment of Polypeptides to Virus Like Particles
US8324149B2 (en) 2008-11-18 2012-12-04 The Board Of Trustees Of The Leland Stanford Junior University Encapsidation of heterologous entities into virus-like particles
US20130295131A1 (en) 2009-11-05 2013-11-07 Hal S. Padgett Generation of antigenic virus-like particles through protein-protein linkages
WO2011109422A2 (en) 2010-03-02 2011-09-09 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of cancer
JP2014527072A (ja) * 2011-09-09 2014-10-09 バイオメド リアルティー, エル.ピー. ウイルスタンパク質の集合を制御するための方法および組成物
US20150071987A1 (en) 2012-02-03 2015-03-12 Emory University Immunostimulatory compositions, particles, and uses related thereto
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
EP2968517A4 (en) 2013-03-15 2017-02-22 Bullet Biotechnology, Inc. Specific multivalent virus-like particle vaccines and uses thereof
JP2017500313A (ja) 2013-12-09 2017-01-05 ブレット バイオテクノロジー, インコーポレーテッドBullet Biotechnology, Inc. 特異的ウイルス様粒子−CpGオリゴヌクレオチドワクチンおよびその使用

Similar Documents

Publication Publication Date Title
JP2015531407A5 (enExample)
JP2012095652A5 (enExample)
JP2005120106A5 (enExample)
RU2012122173A (ru) Варианты альбумина
RU2010108308A (ru) Способ получения гетерогенных белков
JP2019530466A5 (enExample)
JP2014221052A5 (enExample)
DK1885850T3 (da) Fremgangsmåde til fremstilling af D-psicose ved D-psicose-epimerase
RU2011128371A (ru) Модифицированные f протеины sv и способы их применения
JP2016526909A5 (enExample)
JP2007197439A5 (enExample)
ZA202100384B (en) Influenza virus hemagglutinin mutants
JP2007513634A5 (enExample)
JP2020528760A (ja) 新規融合タンパク質の調製およびそのタンパク質合成の向上における使用
JP2014524241A5 (enExample)
JP2011152137A5 (enExample)
CA2567254A1 (en) Tc-83-derived alphavirus vectors, particles and methods
JP2009268467A5 (enExample)
RU2019139064A (ru) Композиции и способы для лечения цитомегаловируса
WO2006119516A3 (en) Expression of viral proteins in plants
MY197457A (en) Chimeric papillomavirus l1 protein
RU2018113521A (ru) Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b
JP2014076042A5 (enExample)
CN104031118B (zh) 鼠多瘤病毒衣壳粒的新型亲和肽配基及其设计筛选方法
PH12021550898A1 (en) Virus-like particles of cmv modified by fusion